FKBPL and preeclampsia: In light of FKBPL’s critical role in developmental, physiological, and pathological angiogenesis as an anti-angiogenic protein (18) via CD44 (17), we investigated both FKBPL and CD44 expression in placental samples from women with and without preeclampsia (Cohort 2, Table 2).